{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:08:09Z","timestamp":1795039689539,"version":"4.10.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Amyloid beta (A\u03b2) plaque deposition in the central nervous system (CNS) is a hallmark of Alzheimer\u2019s disease (AD) and cerebral amyloid angiopathy (CAA), triggering robust innate immune responses. However, the role of the adaptive immune system remains less well understood. Here we show the immune microenvironment dynamics in APP23 transgenic (APP23-tg) mice modelling CNS amyloid pathology, using single-cell transcriptomics. We observed a marked increase in T-cell populations during late disease stages, particularly CD8\u207a T-cells that clustered around A\u03b2 plaques, suggesting a targeted immune response. Among these, we identified an A\u03b2 plaque-associated subset of CD8\u207a T cells expressing interferon-stimulated genes (ISGs), which promoted Type-I interferon signaling. This subset also produced CXCL10, facilitating the recruitment of non-ISG T cells through the CXCL10-CXCR3 axis. Importantly, similar Type-I interferon responses were detected near plaques in human CNS amyloid pathology. Together, these findings highlight a shift from microglia-driven to T-cell-mediated neuroinflammation as amyloid pathology progresses, with implications for time-resolved therapy development.<\/jats:p>","DOI":"10.1038\/s41467-026-72262-6","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:19:53Z","timestamp":1776914393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Type I interferon drives T cell responses to amyloid beta in the central nervous system"],"prefix":"10.1038","volume":"17","author":[{"given":"Julius J.","family":"Michel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0958-1433","authenticated-orcid":false,"given":"Khwab","family":"Sanghvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Rosenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Humbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara Tejido","family":"Dierssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Grudzenski-Theis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"J\u00e4hne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1382-5912","authenticated-orcid":false,"given":"Karoline","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-0813","authenticated-orcid":false,"given":"Lutz","family":"Fr\u00f6lich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6201-1042","authenticated-orcid":false,"given":"Jochen","family":"Herms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Fatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4746-887X","authenticated-orcid":false,"given":"Michael","family":"Platten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4490-7574","authenticated-orcid":false,"given":"Lukas","family":"Bunse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"72262_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"72262_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff, R. M. How neuroinflammation contributes to neurodegeneration. Science 353, 777\u2013783 (2016).","journal-title":"Science"},{"key":"72262_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570, 332\u2013337 (2019).","journal-title":"Nature"},{"key":"72262_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat. Rev. Neurol. 17, 157\u2013172 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"72262_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat. Genet. 54, 412\u2013436 (2022).","journal-title":"Nat. Genet."},{"key":"72262_CR6","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus, H. & Heneka, M. T. Microglia in Alzheimer\u2019s disease. J. Clin. Invest. 127, 3240\u20133249 (2017).","journal-title":"J. Clin. Invest."},{"key":"72262_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen, D. V., Hanson, J. E. & Sheng, M. Microglia in Alzheimer\u2019s disease. J. Cell Biol. 217, 459\u2013472 (2018).","journal-title":"J. Cell Biol."},{"key":"72262_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41590-021-00913-5","volume":"22","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques. Nat. Immunol. 22, 586\u2013594 (2021).","journal-title":"Nat. Immunol."},{"key":"72262_CR9","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"72262_CR10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581.e9 (2017).","journal-title":"Immunity"},{"key":"72262_CR11","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy, E. R. et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J. Clin. Invest. 130, 1912\u20131930 (2020).","journal-title":"J. Clin. Invest."},{"key":"72262_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner, F. L., Ransohoff, R. M. & Becher, B. Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16, 358\u2013372 (2015).","journal-title":"Nat. Rev. Neurosci."},{"key":"72262_CR13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio, C. et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 27, 1293\u20131306.e6 (2019).","journal-title":"Cell Rep."},{"key":"72262_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah, M. et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat. Commun. 11, 6129 (2020).","journal-title":"Nat. Commun."},{"key":"72262_CR15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.immuni.2022.03.018","volume":"55","author":"ER Roy","year":"2022","unstructured":"Roy, E. R. et al. Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid \u03b2 plaques. Immunity 55, 879\u2013894.e6 (2022).","journal-title":"Immunity"},{"key":"72262_CR16","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1126\/science.aay0479","volume":"366","author":"J Rustenhoven","year":"2019","unstructured":"Rustenhoven, J. & Kipnis, J. Bypassing the blood-brain barrier. Science 366, 1448\u20131449 (2019).","journal-title":"Science"},{"key":"72262_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-022-05474-7","volume":"612","author":"J Rustenhoven","year":"2022","unstructured":"Rustenhoven, J. & Kipnis, J. Brain borders at the central stage of neuroimmunology. Nature 612, 417\u2013429 (2022).","journal-title":"Nature"},{"key":"72262_CR18","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.immuni.2022.10.016","volume":"55","author":"X Chen","year":"2022","unstructured":"Chen, X. & Holtzman, D. M. Emerging roles of innate and adaptive immunity in Alzheimer\u2019s disease. Immunity 55, 2236\u20132254 (2022).","journal-title":"Immunity"},{"key":"72262_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01155-w","volume":"15","author":"M Jorfi","year":"2023","unstructured":"Jorfi, M., Maaser-Hecker, A. & Tanzi, R. E. The neuroimmune axis of Alzheimer\u2019s disease. Genome Med. 15, 6 (2023).","journal-title":"Genome Med."},{"key":"72262_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0304-3940(88)90690-8","volume":"91","author":"S Itagaki","year":"1988","unstructured":"Itagaki, S., McGeer, P. L. & Akiyama, H. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer\u2019s disease brain tissue. Neurosci. Lett. 91, 259\u2013264 (1988).","journal-title":"Neurosci. Lett."},{"key":"72262_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0197-4580(88)80079-4","volume":"9","author":"J Rogers","year":"1988","unstructured":"Rogers, J., Luber-Narod, J., Styren, S. D. & Civin, W. H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer\u2019s disease. Neurobiol. Aging 9, 339\u2013349 (1988).","journal-title":"Neurobiol. Aging"},{"key":"72262_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0165-5728(01)00496-9","volume":"124","author":"T Togo","year":"2002","unstructured":"Togo, T. et al. Occurrence of T cells in the brain of Alzheimer\u2019s disease and other neurological diseases. J. Neuroimmunol. 124, 83\u201392 (2002).","journal-title":"J. Neuroimmunol."},{"key":"72262_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/brain\/aww270","volume":"140","author":"C Laurent","year":"2017","unstructured":"Laurent, C. et al. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy. Brain 140, 184\u2013200 (2017).","journal-title":"Brain"},{"key":"72262_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000486200","volume":"18","author":"M Merlini","year":"2018","unstructured":"Merlini, M., Kirabali, T., Kulic, L., Nitsch, R. M. & Ferretti, M. T. Extravascular CD3+ T cells in brains of Alzheimer disease patients correlate with tau but not with amyloid pathology: an immunohistochemical study. Neurodegener. Dis. 18, 49\u201356 (2018).","journal-title":"Neurodegener. Dis."},{"key":"72262_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577, 399\u2013404 (2020).","journal-title":"Nature"},{"key":"72262_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbi.2020.05.070","volume":"89","author":"MS Unger","year":"2020","unstructured":"Unger, M. S. et al. CD8+ T-cells infiltrate Alzheimer\u2019s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice. Brain. Behav. Immun. 89, 67\u201386 (2020).","journal-title":"Brain. Behav. Immun."},{"key":"72262_CR27","doi-asserted-by":"publisher","first-page":"110158","DOI":"10.1016\/j.celrep.2021.110158","volume":"37","author":"S-H Lee","year":"2021","unstructured":"Lee, S.H. et al. TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease. Cell Rep. 37, 110158 (2021).","journal-title":"Cell Rep."},{"key":"72262_CR28","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668\u2013677 (2023).","journal-title":"Nature"},{"key":"72262_CR29","doi-asserted-by":"publisher","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","volume":"113","author":"SE Marsh","year":"2016","unstructured":"Marsh, S. E. et al. The adaptive immune system restrains Alzheimer\u2019s disease pathogenesis by modulating microglial function. Proc. Natl. Acad. Sci. USA 113, E1316\u2013E1325 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72262_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41583-018-0054-8","volume":"19","author":"J G\u00f6tz","year":"2018","unstructured":"G\u00f6tz, J., Bodea, L.-G. & Goedert, M. Rodent models for Alzheimer disease. Nat. Rev. Neurosci. 19, 583\u2013598 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"72262_CR31","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41573-020-0065-9","volume":"19","author":"K Scearce-Levie","year":"2020","unstructured":"Scearce-Levie, K., Sanchez, P. E. & Lewcock, J. W. Leveraging preclinical models for the development of Alzheimer disease therapeutics. Nat. Rev. Drug Discov. 19, 447\u2013462 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"72262_CR32","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. USA 94, 13287\u201313292 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72262_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fnagi.2016.00170","volume":"8","author":"B Reuter","year":"2016","unstructured":"Reuter, B. et al. Development of cerebral microbleeds in the APP23-transgenic mouse model of cerebral amyloid angiopathy\u2014A 9.4 Tesla MRI study. Front. Aging Neurosci. 8, 170 (2016).","journal-title":"Front. Aging Neurosci."},{"key":"72262_CR34","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0197-4580(02)00098-2","volume":"24","author":"PH Kelly","year":"2003","unstructured":"Kelly, P. H. et al. Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiol. Aging 24, 365\u2013378 (2003).","journal-title":"Neurobiol. Aging"},{"key":"72262_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1046\/j.1460-9568.2003.02444.x","volume":"17","author":"D Van Dam","year":"2003","unstructured":"Van Dam, D. et al. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur. J. Neurosci. 17, 388\u2013396 (2003).","journal-title":"Eur. J. Neurosci."},{"key":"72262_CR36","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1111\/bph.14586","volume":"176","author":"C Cristiano","year":"2019","unstructured":"Cristiano, C. et al. Neutralization of IL-17 rescues amyloid-\u03b2-induced neuroinflammation and memory impairment. Br. J. Pharmacol. 176, 3544\u20133557 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"72262_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aay5199","volume":"4","author":"M Ribeiro","year":"2019","unstructured":"Ribeiro, M. et al. Meningeal \u03b3\u03b4 T cell-derived IL-17 controls synaptic plasticity and short-term memory. Sci. Immunol. 4, eaay5199 (2019).","journal-title":"Sci. Immunol."},{"key":"72262_CR38","doi-asserted-by":"publisher","first-page":"109574","DOI":"10.1016\/j.celrep.2021.109574","volume":"36","author":"HC Brigas","year":"2021","unstructured":"Brigas, H. C. et al. IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer\u2019s disease. Cell Rep. 36, 109574 (2021).","journal-title":"Cell Rep."},{"key":"72262_CR39","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.abf7266","volume":"374","author":"D Gate","year":"2021","unstructured":"Gate, D. et al. CD4+ T cells contribute to neurodegeneration in Lewy body dementia. Science 374, 868\u2013874 (2021).","journal-title":"Science"},{"key":"72262_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02446-6","volume":"19","author":"J Fu","year":"2022","unstructured":"Fu, J. et al. The role of Th17 cells\/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A. J. Neuroinflammation 19, 98 (2022).","journal-title":"J. Neuroinflammation"},{"key":"72262_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KHG Mills","year":"2023","unstructured":"Mills, K. H. G. IL-17 and IL-17-producing cells in protection versus pathology. Nat. Rev. Immunol. 23, 38\u201354 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"72262_CR42","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","volume":"317","author":"JR Groom","year":"2011","unstructured":"Groom, J. R. & Luster, A. D. CXCR3 in T cell function. Exp. Cell Res. 317, 620\u2013631 (2011).","journal-title":"Exp. Cell Res."},{"key":"72262_CR43","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature07317","volume":"455","author":"H Ishikawa","year":"2008","unstructured":"Ishikawa, H. & Barber, G. N. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455, 674\u2013678 (2008).","journal-title":"Nature"},{"key":"72262_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4049\/jimmunol.1601999","volume":"199","author":"B Larkin","year":"2017","unstructured":"Larkin, B. et al. Activation of STING in T cells induces type I IFN responses and cell death. J. Immunol. 199, 397\u2013402 (2017).","journal-title":"J. Immunol."},{"key":"72262_CR45","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.4049\/jimmunol.2100737","volume":"209","author":"B Altendorfer","year":"2022","unstructured":"Altendorfer, B. et al. Transcriptomic profiling identifies CD8+ T cells in the brain of aged and alzheimer\u2019s disease transgenic mice as tissue-resident memory T cells. J. Immunol. 209, 1272\u20131285 (2022).","journal-title":"J. Immunol."},{"key":"72262_CR46","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","volume":"81","author":"T Kanekiyo","year":"2014","unstructured":"Kanekiyo, T., Xu, H. & Bu, G. ApoE and A\u03b2 in Alzheimer\u2019s disease: accidental Encounters or Partners? Neuron 81, 740\u2013754 (2014).","journal-title":"Neuron"},{"key":"72262_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49028-z","volume":"15","author":"Z Xia","year":"2024","unstructured":"Xia, Z. et al. Co-aggregation with Apolipoprotein E modulates the function of Amyloid-\u03b2 in Alzheimer\u2019s disease. Nat. Commun. 15, 4695 (2024).","journal-title":"Nat. Commun."},{"key":"72262_CR48","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","volume":"139","author":"C Dansokho","year":"2016","unstructured":"Dansokho, C. et al. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain 139, 1237\u20131251 (2016).","journal-title":"Brain"},{"key":"72262_CR49","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41590-023-01604-z","volume":"24","author":"W Su","year":"2023","unstructured":"Su, W. et al. CXCR6 orchestrates brain CD8+ T cell residency and limits mouse Alzheimer\u2019s disease pathology. Nat. Immunol. 24, 1735\u20131747 (2023).","journal-title":"Nat. Immunol."},{"key":"72262_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8967","volume":"6","author":"K Baruch","year":"2015","unstructured":"Baruch, K. et al. Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer\u2019s disease pathology. Nat. Commun. 6, 7967 (2015).","journal-title":"Nat. Commun."},{"key":"72262_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nri.2015.16","volume":"16","author":"MF Krummel","year":"2016","unstructured":"Krummel, M. F., Bartumeus, F. & G\u00e9rard, A. T-cell migration, search strategies and mechanisms. Nat. Rev. Immunol. 16, 193\u2013201 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"72262_CR52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.immuni.2021.11.002","volume":"55","author":"AJ Ozga","year":"2022","unstructured":"Ozga, A. J. et al. CXCL10 chemokine regulates heterogeneity of the CD8+ T cell response and viral set point during chronic infection. Immunity 55, 82\u201397.e8 (2022).","journal-title":"Immunity"},{"key":"72262_CR53","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","volume":"26","author":"M Jorfi","year":"2023","unstructured":"Jorfi, M. et al. Infiltrating CD8+ T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. Nat. Neurosci. 26, 1489\u20131504 (2023).","journal-title":"Nat. Neurosci."},{"key":"72262_CR54","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/s41593-025-01955-w","volume":"28","author":"J Groh","year":"2025","unstructured":"Groh, J. et al. Microglia activation orchestrates CXCL10-mediated CD8+ T cell recruitment to promote aging-related white matter degeneration. Nat. Neurosci. 28, 1160\u20131173 (2025).","journal-title":"Nat. Neurosci."},{"key":"72262_CR55","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1172\/JCI66771","volume":"125","author":"M Krauthausen","year":"2015","unstructured":"Krauthausen, M. et al. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer\u2019s disease model. J. Clin. Investig. 125, 365\u2013378 (2015).","journal-title":"J. Clin. Investig."},{"key":"72262_CR56","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1136\/ard-2023-225445","volume":"83","author":"T Baker","year":"2024","unstructured":"Baker, T. et al. Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials. Ann. Rheum. Dis. 83, 1018\u20131027 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"72262_CR57","doi-asserted-by":"publisher","first-page":"176403","DOI":"10.1016\/j.ejphar.2024.176403","volume":"968","author":"J Min","year":"2024","unstructured":"Min, J. et al. Ruxolitinib attenuates microglial inflammatory response by inhibiting NF-\u03baB\/MAPK signaling pathway. Eur. J. Pharmacol. 968, 176403 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"72262_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Dyck","year":"2023","unstructured":"Dyck, C. H. et al. Lecanemab in Early Alzheimer\u2019s Disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"72262_CR59","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/alz.13512","volume":"20","author":"L Kelly","year":"2024","unstructured":"Kelly, L. et al. Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-\u03b2 from the brain and retina with age and Alzheimer\u2019s disease: opportunities for therapy. Alzheimers Dement 20, 1421\u20131435 (2024).","journal-title":"Alzheimers Dement"},{"key":"72262_CR60","doi-asserted-by":"publisher","first-page":"e1265","DOI":"10.1212\/WNL.0000000000200892","volume":"99","author":"F Piazza","year":"2022","unstructured":"Piazza, F. et al. Association of microglial activation with spontaneous ARIA-E and CSF levels of anti-A\u03b2 autoantibodies. Neurology 99, e1265\u2013e1277 (2022).","journal-title":"Neurology"},{"key":"72262_CR61","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1212\/WNL.0000000000012778","volume":"97","author":"L Antolini","year":"2021","unstructured":"Antolini, L. et al. Spontaneous ARIA-like events in cerebral amyloid angiopathy\u2013related inflammation. Neurology 97, e1809\u2013e1822 (2021).","journal-title":"Neurology"},{"key":"72262_CR62","doi-asserted-by":"crossref","unstructured":"Hu, D. et al. ApoE \u03b54-dependent alteration of CXCR3+CD127+ CD4+ T cells is associated with elevated plasma neurofilament light chain in Alzheimer\u2019s disease. J Alzheimers Dis. 104, 792\u2013807 (2025).","DOI":"10.1177\/13872877251320123"},{"key":"72262_CR63","doi-asserted-by":"publisher","unstructured":"Groiss, S. et al. Highly resolved spatial transcriptomics for detection of rare events in cells. Preprint at https:\/\/doi.org\/10.1101\/2021.10.11.463936 (2021).","DOI":"10.1101\/2021.10.11.463936"},{"key":"72262_CR64","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s12264-023-01175-x","volume":"40","author":"H Fu","year":"2024","unstructured":"Fu, H. et al. A\u03b2-aggregation-generated blue autofluorescence illuminates senile plaques as well as complex blood and vascular pathologies in Alzheimer\u2019s disease. Neurosci. Bull. 40, 1115\u20131126 (2024).","journal-title":"Neurosci. Bull."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72262-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72262-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72262-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T05:02:19Z","timestamp":1776920539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72262-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72262"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72262-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5140494\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.P.s is the founder of TcellTech. All other authors declare no conflict.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3737"}}